Regulator Rejects Claim Non-Compliance Drives Drug Shortages
SAHPRA says shortages of critical medicines have multiple causes and are not necessarily linked to regulatory compliance interventions.
Updated on Nov. 11, 2026 in Healthcare

Live Poll
Do you trust the government to keep essential medicines consistently available?
The South African Health Products Regulatory Authority (SAHPRA) rejected a claim by the National Department of Health that drug shortages are partly caused by local manufacturers failing to comply with its requirements. Public hospitals and clinics are running short of medicines for hypertension, diabetes and severe mental illnesses.
Why it matters
The dispute raises questions about what is driving shortages of essential medicines and who is responsible for resolving them. Competing explanations from the health department and the regulator leave patients and providers without a clear account of the problem.
SAHPRA has not released figures on the number of manufacturers inspected or found non-compliant, nor the dates of those inspections. The extent of the shortages has not been quantified, and the South African Society of Psychiatrists and the Pharmaceutical Society of South Africa both say reliable information is lacking.
The players
South African Health Products Regulatory Authority (SAHPRA)
SAHPRA is the national regulator responsible for approving and inspecting medicines and other health products sold in South Africa.
National Department of Health
The National Department of Health is the national government department responsible for public health policy and the procurement of medicines for public facilities.
The details
SAHPRA said shortages are multi-factorial and that regulatory compliance interventions are not necessarily their sole cause. The National Department of Health is engaging with suppliers and procuring alternative medicines from other sources. The South African Society of Psychiatrists warned that essential psychiatric drugs are in short supply in Gauteng, KwaZulu-Natal, the Western Cape and the Eastern Cape.
Timeline
The National Department of Health blamed manufacturers' non-compliance for the shortages in the week before 10 November 2026.
SAHPRA rejected that claim in a statement on 10 November 2026.
Health Landscape
The dispute sits within South Africa's ongoing reliance on imported active ingredients and global supply chains for public-sector medicines. SAHPRA's routine inspection regime requires manufacturers to implement corrective and preventive actions wherever deficiencies are found.
Patients may be temporarily switched to clinically appropriate alternative medicines until supply constraints are resolved. Anyone relying on hypertension, diabetes or psychiatric medication should speak to their healthcare provider about available options if their usual supply is disrupted.
The takeaway
Patients on long-term medication should check supply with their clinic or pharmacy early, rather than waiting until stock runs out. Clear, verified data from the regulator and health department would help the public judge how far the shortages extend.
Further reading
Explore more on healthcare developments affecting public medicine supply across South Africa.
Source note: This article includes information reported by Juta MedicalBrief.
Live Poll
Do you trust the government to keep essential medicines consistently available?






